Tags

Type your tag names separated by a space and hit enter

Phylloquinone supplementation improves glycemic status independent of the effects of adiponectin levels in premonopause women with prediabetes: a double-blind randomized controlled clinical trial.
J Diabetes Metab Disord 2015; 14(1):1JD

Abstract

BACKGROUND

Vitamin K, as a cofactor in the gamma carboxylation of certain glutamic acid (Gla) residues, has been related to glucose metabolism and insulin sensitivity. Osteocalcin, also known as bone γ-carboxyglutamic acid, increases β-cell proliferation as well as insulin and adiponectin secretion, which improve glucose tolerance and insulin sensitivity. Thus, the purpose of the present study was to examine the possible role of adiponectin as a mediator of glucose homeostasis following phylloquinone supplementation in premonopause women with prediabetes.

METHODS

Eighty two women were randomized to consume vitamin k1 supplement (n = 39) or placebo (n = 43) for four weeks. Participants in vitamin K1 treatment group received one pearl softgel capsule containing 1000 micrograms phylloquinone while the placebo group received one placebo capsules daily for four weeks. The Blood samples were collected at baseline and after a four-week intervention to quantify osteocalcin, adiponectin, leptin and relevant variables.

RESULTS

Phylloquinone supplementation significantly increased serum adiponectin concentration (1.24 ± 1.90 compared with -0.27 ± 1.08 μg/ml), and did not alter total osteocalcin (0.50 ± 4.11 compared with 0.13 ± 1.85 ng/ml) and leptin (-0.29 ± 8.23 compared with -1.15 ± 5.25 ng/ml) compared with placebo. Adjustments for total osteocalcin and adiponectin using analysis of covariance (ANCOVA) did not affect the association of glycemic status with related variables.

CONCLUSIONS

In conclusion our study demonstrated that phylloquinone supplementation improved glycemic status in premonopausal prediabetic women independent of adiponectin.

TRIAL REGISTRATION

This trial was registered in Iranian Registry of Clinical Trials with ID number of IRCT2013120915724N1.

Authors+Show Affiliations

Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.Hyperlipidemia Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.Department of Food Hygiene, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran.Department of Biostatistics and Epidemiology, School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

25654061

Citation

Rasekhi, Hamid, et al. "Phylloquinone Supplementation Improves Glycemic Status Independent of the Effects of Adiponectin Levels in Premonopause Women With Prediabetes: a Double-blind Randomized Controlled Clinical Trial." Journal of Diabetes and Metabolic Disorders, vol. 14, no. 1, 2015, p. 1.
Rasekhi H, Karandish M, Jalali MT, et al. Phylloquinone supplementation improves glycemic status independent of the effects of adiponectin levels in premonopause women with prediabetes: a double-blind randomized controlled clinical trial. J Diabetes Metab Disord. 2015;14(1):1.
Rasekhi, H., Karandish, M., Jalali, M. T., Mohammadshahi, M., Zarei, M., Saki, A., & Shahbazian, H. (2015). Phylloquinone supplementation improves glycemic status independent of the effects of adiponectin levels in premonopause women with prediabetes: a double-blind randomized controlled clinical trial. Journal of Diabetes and Metabolic Disorders, 14(1), p. 1. doi:10.1186/s40200-014-0127-9.
Rasekhi H, et al. Phylloquinone Supplementation Improves Glycemic Status Independent of the Effects of Adiponectin Levels in Premonopause Women With Prediabetes: a Double-blind Randomized Controlled Clinical Trial. J Diabetes Metab Disord. 2015;14(1):1. PubMed PMID: 25654061.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Phylloquinone supplementation improves glycemic status independent of the effects of adiponectin levels in premonopause women with prediabetes: a double-blind randomized controlled clinical trial. AU - Rasekhi,Hamid, AU - Karandish,Majid, AU - Jalali,Mohammad-Taha, AU - Mohammadshahi,Majid, AU - Zarei,Mehdi, AU - Saki,Azadeh, AU - Shahbazian,Hajieh, Y1 - 2015/01/14/ PY - 2014/07/06/received PY - 2014/12/28/accepted PY - 2015/2/6/entrez PY - 2015/2/6/pubmed PY - 2015/2/6/medline KW - Adiponectin KW - Osteocalcin KW - Phylloquinone KW - Prediabetes KW - Vitamin K1 SP - 1 EP - 1 JF - Journal of diabetes and metabolic disorders JO - J Diabetes Metab Disord VL - 14 IS - 1 N2 - BACKGROUND: Vitamin K, as a cofactor in the gamma carboxylation of certain glutamic acid (Gla) residues, has been related to glucose metabolism and insulin sensitivity. Osteocalcin, also known as bone γ-carboxyglutamic acid, increases β-cell proliferation as well as insulin and adiponectin secretion, which improve glucose tolerance and insulin sensitivity. Thus, the purpose of the present study was to examine the possible role of adiponectin as a mediator of glucose homeostasis following phylloquinone supplementation in premonopause women with prediabetes. METHODS: Eighty two women were randomized to consume vitamin k1 supplement (n = 39) or placebo (n = 43) for four weeks. Participants in vitamin K1 treatment group received one pearl softgel capsule containing 1000 micrograms phylloquinone while the placebo group received one placebo capsules daily for four weeks. The Blood samples were collected at baseline and after a four-week intervention to quantify osteocalcin, adiponectin, leptin and relevant variables. RESULTS: Phylloquinone supplementation significantly increased serum adiponectin concentration (1.24 ± 1.90 compared with -0.27 ± 1.08 μg/ml), and did not alter total osteocalcin (0.50 ± 4.11 compared with 0.13 ± 1.85 ng/ml) and leptin (-0.29 ± 8.23 compared with -1.15 ± 5.25 ng/ml) compared with placebo. Adjustments for total osteocalcin and adiponectin using analysis of covariance (ANCOVA) did not affect the association of glycemic status with related variables. CONCLUSIONS: In conclusion our study demonstrated that phylloquinone supplementation improved glycemic status in premonopausal prediabetic women independent of adiponectin. TRIAL REGISTRATION: This trial was registered in Iranian Registry of Clinical Trials with ID number of IRCT2013120915724N1. SN - 2251-6581 UR - https://www.unboundmedicine.com/medline/citation/25654061/full_citation L2 - https://jdmdonline.biomedcentral.com/articles/10.1186/s40200-014-0127-9 DB - PRIME DP - Unbound Medicine ER -